A phase II study of combination chemotherapy with carboplatin plus S-1 in advanced and recurrence non small cell lung cancer - A phase II study of combination chemotherapy with carboplatin plus S-1 in advanced and recurrence non small cell lung cancer

ational Hospital Organization Osaka0 sites20 target enrollmentMarch 7, 2013

Overview

No summary available.

Registry

who.int

Start Date

March 7, 2013

End Date

September 30, 2018

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Sponsor

ational Hospital Organization Osaka

•1\)Patients with interstitial pneumonia or pulmonary fibrosis on Chest X\-ray 2\)Patients with pleural or pericardial effusion ,or ascites 3\) Patients with active double cancer 4\)Patients with significant complications a) Uncontrolled angina pectoris, myocardial infarction, heart failure within 3 months b)Uncontrolled diabetes or hypertension c)Current severe infection, or suspicious of severe infection d) Patients whose participation in the trial is judged to be inappropriate by the attending doctor. (e.g., ileus, bleeding tendency, diarrhea and varicella) 5\)Patients with symptomatic brain metastasis 6\)Patients with pregnancy or lactation 7\) History of serious drug allergy 8\) History of serious allergic reaction with CBDCA or other platinum\-containing drug 9\) History of serious allergic reaction with S\-1 10\) Being treated with other pyrimidine fluoride antineoplastic agents. 11\) Being treated with flucytosine. 12\) Any patients judged by the investigator to be unfit to participate in the study